Biophysical characterization of VP3 binding to PI3P.
(A) Immunoblots of the top (T) and bottom (B) fractions from a liposome PI3P(-) or PI3P(+) OptiprepTM co-floatation assay indicating that His-2xFYVE protein specifically binds to liposome PI3P(+). Results are representative of three independent experiments. The bar plot represents the intensity of T/B bands for each liposome preparation. Significant differences (** P <0.01) as determined by one-way ANOVA with Tukey’s HSD test.
(B) Immunoblots of the three top (T1, T2 and T3) and bottom (B) fractions from a liposome PI3P(-) or PI3P(+) OptiprepTM co-floatation assay indicating that His-VP3 FL protein specifically binds to liposome PI3P(+). Results are representative of three independent experiments. The bar plot represents the intensity of (T1+T2+T3)/B bands for each liposome preparation. Significant differences (* P <0.05) as determined by one-way ANOVA with Tukey’s HSD test.
(C) Cryo-electron microscopy images of cryo-fixated liposomes PI3P(+) control (without protein), or incubated with His-2xFYVE- or His-VP3 FL-Ni-NTA gold particles showing gold particles decorating the membrane of the liposomes when His-2xFYVE or His-VP3 FL were present. The bar represents 50 nm.
(D) Binding of His-Streptavidin (negative control), His-2xFYVE (positive control) or His-VP3 FL to three different concentrations of liposomes PI3P(-) or PI3P(+). Association and dissociation sensorgrams measured by bio-layer interferometry (BLI), showing the specific interaction of His-2xFYVE and His-VP3 FL with liposomes PI3P(+) in a dose-dependent manner, as indicated.
(E) Cartoon representation of AlphaFold prediction of VP3 FL. Red region corresponds to the “core” region of the protein present in the experimental X-ray crystallographic model obtained by Casañas et al., 2008 [PDB: 2R18 (Casañas et al., 2008)]. Regions not present within the PDB are colored in violet and blue representing the Nt and the Ct of VP3, respectively. pLDTT values lower than 50 are a strong predictor of disorder.
(F) Binding of His-VP3 DCt to three different concentrations of liposomes PI3P(-) or PI3P(+). Sensorgrams measured by BLI, showing the absence of binding to either liposomes when the VP3 lacks the Ct region [blue in (E)].
(G) Immunoblots of the three top (T1, T2 and T3) and bottom (B) fractions from a liposome PI3P(-) or PI3P(+) OptiprepTM co-floatation assay of His-VP3 FL protein (positive control, left panel) or His-VP3 DCt (right panel) showing the lack of VP3 DCt binding to both liposomes. Results are representative of three independent experiments. The bar plot represents the intensity of (T1+T2+T3)/B bands for each liposome preparation. Significant differences (* P <0.05; ns P >0.05) as determined by one-way ANOVA with Tukey’s HSD test.